Safety review update of Revlimid and risk of developing new types of malignancies October 03, 2017Vol.40 No.08
Two Opdivo trials show three-year survival in patients with previously treated advanced NSCLC October 03, 2017Vol.40 No.08
Peter Pisters hits the right notes in town hall meeting at MD Anderson September 29, 2017Vol.43 No.36By Paul Goldberg
In draft, USPSTF recommends screening with hrHPV without cytology September 29, 2017Vol.43 No.36By Matthew Bin Han Ong
Guest Editorial A costly “rebranding” of an old drug comes with a 700% price increase September 29, 2017Vol.43 No.36By Jason Funaro, Henry S. Friedman and Mallika Weant
In Brief CancerCare expands financial assistance for patients affected by hurricanes September 29, 2017Vol.43 No.36
In Brief Research!America to honor chair emeritus John Edward Porter and medical and health research advocacy leaders September 29, 2017Vol.43 No.36
In Brief Fox Chase Cancer Center receives gift to establish pancreatic cancer institute September 29, 2017Vol.43 No.36
In Brief Linus Chuang named chairman of obstetrics and gynecology at Western Connecticut Health Network September 29, 2017Vol.43 No.36
Drugs & Targets FDA approves Verzenio for advanced or metastatic breast cancers September 29, 2017Vol.43 No.36
